Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:48:59 UTC |
---|
HMDB ID | HMDB0000063 |
---|
Secondary Accession Numbers | - HMDB00063
- HMDB0014879
- HMDB14879
|
---|
Metabolite Identification |
---|
Common Name | Cortisol |
---|
Description | Cortisol is the main glucocorticoid secreted by the adrenal cortex and it is involved in the stress response. Its synthetic counterpart hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Hydrocortisone is synthesized from pregnenolone and is used as an immunosuppressive drug given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning and lower levels in the evening, several hours after the onset of sleep. Cortisol is found to be associated with ACTH deficiency and glucocorticoid deficiency, which are inborn errors of metabolism. Cortisol binds to the cytosolic glucocorticoid receptor. After binding the receptor, the newly formed receptor-ligand complex translocates itself into the cell nucleus where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA-bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically, glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes and prevents phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products of inflammation, prostaglandins and leukotrienes, are inhibited by the action of glucocorticoids. Glucocorticoids also stimulate the escape of lipocortin-1 into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst, and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines, etc.) from neutrophils, macrophages, and mastocytes. Additionally, the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. |
---|
Structure | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione | ChEBI | 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione | ChEBI | 11beta-Hydrocortisone | ChEBI | 17-Hydroxycorticosterone | ChEBI | 4-Pregnen-11beta,17alpha,21-triol-3,20-dione | ChEBI | Hidrocortisona | ChEBI | Hydrocortisone | ChEBI | Hydrocortisonum | ChEBI | Kendall's compound F | ChEBI | Reichstein's substance m | ChEBI | HC | Kegg | Acticort | Kegg | Anusol HC | Kegg | Colocort | Kegg | Cortef | Kegg | Hytone | Kegg | Plenadren | Kegg | (11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione | Generator | (11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione | Generator | 11b,17a,21-Trihydroxy-4-pregnene-3,20-dione | Generator | 11Β,17α,21-trihydroxy-4-pregnene-3,20-dione | Generator | 11b-Hydrocortisone | Generator | 11Β-hydrocortisone | Generator | 4-Pregnen-11b,17a,21-triol-3,20-dione | Generator | 4-Pregnen-11β,17α,21-triol-3,20-dione | Generator | 11beta-Hydroxycortisone | HMDB | 17alpha-Hydroxycorticosterone | HMDB | Anti-inflammatory hormone | HMDB | Dihydrocostisone | HMDB | Hydrocorticosterone | HMDB | Hydrocortisone acetate | HMDB | Hydrocortisone alcohol | HMDB | Hydrocortisone base | HMDB | Hydrocortisone butyrate | HMDB | Hydrocortisone free alcohol | HMDB | Hydrocortisone sodium phosphate | HMDB | Hydrocortisone valerate | HMDB | Hydroxycortisone | HMDB | Idrocortisone | HMDB | Balneol-HC | ChEMBL, HMDB | CORTRIL | ChEMBL, HMDB, MeSH | Cetacort | ChEMBL, HMDB | Cort-dome | ChEMBL, HMDB | Flexicort | ChEMBL, HMDB | Hi-cor | ChEMBL, HMDB | Hydrocortisone in absorbase | ChEMBL, HMDB | Nogenic HC | ChEMBL, HMDB | Aeroseb-HC | ChEMBL, HMDB | Ala-cort | ChEMBL, HMDB | Ala-scalp | ChEMBL, HMDB | Penecort | ChEMBL, HMDB | Texacort | ChEMBL, HMDB | H-Cort | ChEMBL, HMDB | HYDROCORTONE | ChEMBL, HMDB | Ophthocort | ChEMBL, HMDB | Terra-cortril | ChEMBL, HMDB | Cor-oticin | ChEMBL, HMDB | Nutracort | ChEMBL, HMDB | Cortifoam | ChEMBL, HMDB | Glycort | ChEMBL, HMDB | HC #1 | ChEMBL, HMDB | HC #4 | ChEMBL, HMDB | Proctocort | ChEMBL, HMDB | Anucort-HC | ChEMBL, HMDB | Cortenema | ChEMBL, HMDB | Dermacort | ChEMBL, HMDB | Micort-HC | ChEMBL, HMDB | Synacort | ChEMBL, HMDB | U-cort | ChEMBL, HMDB | Eldecort | ChEMBL, HMDB | Epicort | ChEMBL, HMDB | neo-Cortef | ChEMBL, HMDB | Stie-cort | ChEMBL, HMDB | Anusol-HC | ChEMBL, HMDB | Beta-HC | ChEMBL, HMDB | hydro-RX | ChEMBL, HMDB | Locoid | ChEMBL, HMDB | b-HC | Generator, HMDB | β-HC | Generator, HMDB | 11-beta-Hydrocortisone | HMDB | 11-beta-Hydroxycortisone | HMDB | 11-Hydrocortisone | HMDB | 11a-Hydroxycorticosterone | HMDB | 11alpha-Hydroxycorticosterone | HMDB | 11b,17,21-Trihydroxyprogesterone | HMDB | 11b-Hydroxycortisone | HMDB | 11beta,17,21-Trihydroxyprogesterone | HMDB | 17a-Hydroxycorticosterone | HMDB | 4-Pregnene-11alpha,21-triol 3,20-dione | HMDB | 4-Pregnene-11b,17a,21-triol-3,20-dione | HMDB | Aeroseb HC | HMDB | Alacort | HMDB | Algicirtis | HMDB | Alphaderm | HMDB | Amberin | HMDB | Anflam | HMDB | Aquacort | HMDB | Aquanil HC | HMDB | Barseb HC | HMDB | Basan-corti | HMDB | CaldeCORT spray | HMDB | Chronocort | HMDB | Clear aid | HMDB | Cleiton | HMDB | Cobadex | HMDB | Compound F | HMDB | Cor-tar-quin | HMDB | Cort-quin | HMDB | Cortanal | HMDB | Cortesal | HMDB | Corticreme | HMDB | Cortifan | HMDB | Cortiment | HMDB | Cortisol alcohol | HMDB | Cortisolonum | HMDB | Cortisporin | HMDB | Cortisporin otico | HMDB | Cortispray | HMDB | Cortizol | HMDB | Cortolotion | HMDB | Cortonema | HMDB | Cortoxide | HMDB | Cremesone | HMDB | Cremicort-H | HMDB | Cutisol | HMDB | Delacort | HMDB | Derm-aid | HMDB | Dermil | HMDB | Dermolate | HMDB | Dioderm | HMDB | Dome-cort | HMDB | Domolene-HC | HMDB | Drotic | HMDB | Ef corlin | HMDB | Efcorbin | HMDB | Efcortelan | HMDB | Efcortelin | HMDB | Eldercort | HMDB | Epiderm H | HMDB | Esiderm H | HMDB | Evacort | HMDB | Ficortril | HMDB | Fiocortril | HMDB | Foille insetti | HMDB | Genacort | HMDB | gyno-Cortisone | HMDB | Heb cort | HMDB | Heb-cort | HMDB | Hidalone | HMDB | hidro-Colisona | HMDB | Hycort | HMDB | Hycortol | HMDB | Hycortole | HMDB | Hydracort | HMDB | Hydrasson | HMDB | hydro-Adreson | HMDB | hydro-Colisona | HMDB | Hydrocort | HMDB | Hydrocortal | HMDB | Hydrocortistab | HMDB | Hydrocortisyl | HMDB | Hydroskin | HMDB | Hysone | HMDB | Hytisone | HMDB | Hytone lotion | HMDB | Incortin-H | HMDB | Incortin-hydrogen | HMDB | Komed HC | HMDB | Kyypakkaus | HMDB | Lacticare HC | HMDB | Lacticare-HC | HMDB | Lactisona | HMDB | Lubricort | HMDB | Maintasone | HMDB | Medicort | HMDB | Meusicort | HMDB | Mildison | HMDB | Milliderm | HMDB | neo-Cort-dome | HMDB | Neosporin-H ear | HMDB | Nystaform-HC | HMDB | Optef | HMDB | Otalgine | HMDB | Otic-neo-cort-dome | HMDB | Otobiotic | HMDB | Otocort | HMDB | Otosone-F | HMDB | Pediotic suspension | HMDB | Permicort | HMDB | Polcort H | HMDB | Preparation H hydrocortisone cream | HMDB | Prepcort | HMDB | Prestwick_265 | HMDB | Prevex HC | HMDB | Proctofoam | HMDB | Protocort | HMDB | Racet | HMDB | Rectoid | HMDB | Remederm HC | HMDB | Sanatison | HMDB | Scalpicin capilar | HMDB | Schericur | HMDB | Scheroson F | HMDB | Sigmacort | HMDB | Signef | HMDB | Stiefcorcil | HMDB | Systral hydrocort | HMDB | Tarcortin | HMDB | Timocort | HMDB | Topicort | HMDB | Transderma H | HMDB | Traumaide | HMDB | Uniderm | HMDB | Vioform-hydrocortisone | HMDB | VoSol HC | HMDB | Vytone | HMDB | Zenoxone | HMDB | 11-Epicortisol | MeSH, HMDB | Hydrocortisone, (11 alpha)-isomer | MeSH, HMDB | Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer | MeSH, HMDB | 11 Epicortisol | MeSH, HMDB | Cortifair | MeSH, HMDB | Epicortisol | MeSH, HMDB |
|
---|
Chemical Formula | C21H30O5 |
---|
Average Molecular Weight | 362.4599 |
---|
Monoisotopic Molecular Weight | 362.20932407 |
---|
IUPAC Name | (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
CAS Registry Number | 50-23-7 |
---|
SMILES | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
---|
InChI Key | JYGXADMDTFJGBT-VWUMJDOOSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Hydroxysteroids |
---|
Direct Parent | 21-hydroxysteroids |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- 20-oxosteroid
- Pregnane-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- Oxosteroid
- 11-beta-hydroxysteroid
- 11-hydroxysteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- Alpha-hydroxy ketone
- Secondary alcohol
- Ketone
- Cyclic ketone
- Primary alcohol
- Alcohol
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 220 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.32 mg/mL | Not Available | LogP | 1.61 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Cortisol,1TMS,isomer #1 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO | 3358.0 | Semi standard non polar | 33892256 | Cortisol,1TMS,isomer #2 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO[Si](C)(C)C | 3316.6 | Semi standard non polar | 33892256 | Cortisol,1TMS,isomer #3 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO | 3289.8 | Semi standard non polar | 33892256 | Cortisol,1TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO)O[Si](C)(C)C | 3261.7 | Semi standard non polar | 33892256 | Cortisol,1TMS,isomer #5 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO | 3240.4 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO | 3270.0 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #10 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO)O[Si](C)(C)C | 3175.1 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #2 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3400.6 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #3 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO | 3262.2 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3284.4 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #5 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO[Si](C)(C)C | 3252.9 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #6 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO[Si](C)(C)C | 3240.2 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #7 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3303.6 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #8 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO | 3149.6 | Semi standard non polar | 33892256 | Cortisol,2TMS,isomer #9 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO)O[Si](C)(C)C | 3188.3 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3298.7 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #10 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO)O[Si](C)(C)C | 3065.4 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #2 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO | 3157.5 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #3 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3190.1 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3279.6 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #5 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3322.3 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #6 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3196.2 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #7 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO[Si](C)(C)C | 3133.6 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #8 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3179.5 | Semi standard non polar | 33892256 | Cortisol,3TMS,isomer #9 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3167.1 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3180.5 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3195.9 | Standard non polar | 33892256 | Cortisol,4TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=O)CO[Si](C)(C)C | 3444.2 | Standard polar | 33892256 | Cortisol,4TMS,isomer #2 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3216.9 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #2 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3153.0 | Standard non polar | 33892256 | Cortisol,4TMS,isomer #2 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3456.4 | Standard polar | 33892256 | Cortisol,4TMS,isomer #3 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3105.0 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #3 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3138.7 | Standard non polar | 33892256 | Cortisol,4TMS,isomer #3 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO)O[Si](C)(C)C | 3520.9 | Standard polar | 33892256 | Cortisol,4TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3186.3 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3275.5 | Standard non polar | 33892256 | Cortisol,4TMS,isomer #4 | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3528.0 | Standard polar | 33892256 | Cortisol,4TMS,isomer #5 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3061.9 | Semi standard non polar | 33892256 | Cortisol,4TMS,isomer #5 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3166.5 | Standard non polar | 33892256 | Cortisol,4TMS,isomer #5 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3581.6 | Standard polar | 33892256 | Cortisol,5TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3104.0 | Semi standard non polar | 33892256 | Cortisol,5TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3182.8 | Standard non polar | 33892256 | Cortisol,5TMS,isomer #1 | C[C@]12C[C@H](O[Si](C)(C)C)[C@H]3[C@@H](CCC4=CC(O[Si](C)(C)C)=CC[C@@]43C)[C@@H]1CC[C@]2(O[Si](C)(C)C)C(=CO[Si](C)(C)C)O[Si](C)(C)C | 3425.9 | Standard polar | 33892256 | Cortisol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3604.8 | Semi standard non polar | 33892256 | Cortisol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3605.1 | Semi standard non polar | 33892256 | Cortisol,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(=O)CO)[C@@H]2CCC3=CC(=O)CC[C@]3(C)[C@@H]12 | 3528.1 | Semi standard non polar | 33892256 | Cortisol,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(=CO)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3508.3 | Semi standard non polar | 33892256 | Cortisol,1TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]12 | 3506.5 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3899.0 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #10 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O)[C@@H]12 | 3647.3 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O[Si](C)(C)C(C)(C)C)C(=O)CO)[C@@H]2CCC3=CC(=O)CC[C@]3(C)[C@@H]12 | 3734.8 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=CO)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3783.8 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]12 | 3743.0 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3756.3 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3783.7 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3726.7 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #8 | CC(C)(C)[Si](C)(C)OC(=CO)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3649.8 | Semi standard non polar | 33892256 | Cortisol,2TBDMS,isomer #9 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3608.8 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 4002.3 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #10 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3739.4 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 4032.0 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3979.2 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(=CO)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3893.2 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=O)CO)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3804.0 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O)[C@@H]12 | 3900.8 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3848.8 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #8 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3779.3 | Semi standard non polar | 33892256 | Cortisol,3TBDMS,isomer #9 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3871.3 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 4082.3 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3967.0 | Standard non polar | 33892256 | Cortisol,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3709.9 | Standard polar | 33892256 | Cortisol,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 4015.1 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3977.9 | Standard non polar | 33892256 | Cortisol,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3701.9 | Standard polar | 33892256 | Cortisol,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 4098.3 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3994.9 | Standard non polar | 33892256 | Cortisol,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C | 3782.3 | Standard polar | 33892256 | Cortisol,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3953.9 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3891.7 | Standard non polar | 33892256 | Cortisol,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@H]1[C@@H]3CC[C@](O[Si](C)(C)C(C)(C)C)(C(=CO)O[Si](C)(C)C(C)(C)C)[C@@]3(C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]12 | 3776.1 | Standard polar | 33892256 | Cortisol,4TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3902.4 | Semi standard non polar | 33892256 | Cortisol,4TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3913.6 | Standard non polar | 33892256 | Cortisol,4TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3850.4 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Cortisol GC-MS (2 MEOX; 3 TMS) | splash10-0f7o-3930000000-b7b43b2fc9f20acfd20b | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Cortisol GC-MS (Non-derivatized) | splash10-0f7o-3930000000-b7b43b2fc9f20acfd20b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Cortisol GC-EI-TOF (Non-derivatized) | splash10-052f-2910000000-2625335a031486ecb302 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (3 TMS) - 70eV, Positive | splash10-03di-0764390000-da961c85fe1bb83113dd | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cortisol GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-qTof , Positive-QTOF | splash10-03di-0759000000-b337a46ecfd6de91776b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-qTof , Positive-QTOF | splash10-05fs-3940000000-2bf712a915c3a2c100a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-IT , negative-QTOF | splash10-015a-0189000000-61afe49a8d4a96aae3f9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol Linear Ion Trap , negative-QTOF | splash10-00lu-0149000000-b95a11b27f7e7d44dd51 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol Linear Ion Trap , negative-QTOF | splash10-001l-0019000000-4c4924e6ac472ad52886 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol , negative-QTOF | splash10-001j-0259000000-fda4e876e9ef04015946 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-03di-0009000000-cc8188e19dbdd6210b77 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-07r1-1985000000-b6d756bd554367393be3 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-00dj-1930000000-120dc8893cc4709c1f6b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-00dm-2910000000-d1f01e1bce5fe0108f40 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-05tf-3900000000-4ffd79c22013fe5479b6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-054o-4900000000-fdbed869a0cadc21b64b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-002f-7900000000-dac7b2c5b3f8e8b85086 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-016u-7900000000-3a770c3819f82ea45841 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol LC-ESI-QFT , positive-QTOF | splash10-016r-9800000000-d261cf7141fbf30715f5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol Linear Ion Trap , positive-QTOF | splash10-056r-0289000000-9a48511b5c3d5fa404e9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol , positive-QTOF | splash10-03di-0759000000-b337a46ecfd6de91776b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol , positive-QTOF | splash10-05fs-3940000000-2bf712a915c3a2c100a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cortisol 20V, Positive-QTOF | splash10-03di-0259000000-4a5fba6c9c5e205dd239 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 10V, Positive-QTOF | splash10-01ot-0019000000-8ad3f8da375dbe757f56 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 20V, Positive-QTOF | splash10-01r2-0249000000-626e28356285f53f3fe6 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 40V, Positive-QTOF | splash10-0a5i-1591000000-0e29016542b4be9b2b71 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 10V, Negative-QTOF | splash10-03di-0009000000-50ebf457069ff74ed883 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 20V, Negative-QTOF | splash10-114u-2029000000-385a70405fc241c4d5a4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cortisol 40V, Negative-QTOF | splash10-0a4i-9086000000-3eda615d9551e69f2b4a | 2016-08-03 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
- Mitochondria
- Endoplasmic reticulum
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Bladder
- Brain
- Epidermis
- Fibroblasts
- Intestine
- Kidney
- Leukocyte
- Liver
- Neuron
- Ovary
- Pancreas
- Placenta
- Platelet
- Prostate
- Skeletal Muscle
- Spleen
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.287 +/- 0.099 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0130-0.340 uM | Newborn (2 - <15 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0.014-0.46 uM | Infant (15 days - <1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.048-0.30 uM | Children (1 - <9 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.060-0.35 uM | Children (9 - <14 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.077-0.45 uM | Adolescent (14 - <17 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.097-0.51 uM | Adolescent (17 - <19 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.150-0.650 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.028-0.634 uM | Newborn (0-30 days old) | Male | Normal | | details | Blood | Detected and Quantified | 0.32 +/- 0.19 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.221-0.690 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.199 (0.058-0.475) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.359 (0.130-0.519) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.171 +/- 0.0662 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.427 (0.110-0.744) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.386 (0.100-0.671) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.348 (0.090-0.605) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.313 (0.081-0.545) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.282 (0.073-0.491) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.255 (0.066-0.443) uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 0.171-0.538 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected and Quantified | 0083-0.635 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.07-0.55 uM | Children (1 - 13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.138-0.690 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.46 +/- 0.30 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.260-0.719 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.14 (0.0-0.28) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.052 +/- 0.023 uM | Elderly (>65 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.02 +/- 0.011 uM | Adult (>18 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.03 +/- 0.005 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.0069 +/- 0.0058 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0063 +/- 0.0052 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0063 +/- 0.005 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0077 +/- 0.0052 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 2.35 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0081 (0.0019-0.014) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.016(0.012-0.021) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <0.00960 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.00184-0.0184 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.0061 +/- 0.00064 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 1.036 uM | Children (1-13 years old) | Male | 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency | | details | Blood | Detected and Quantified | 0.235 uM | Newborn (0-30 days old) | Female | Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete | | details | Blood | Detected and Quantified | 0.0124-0.455 uM | Newborn (0-30 days old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | <0.0276 uM | Newborn (0-30 days old) | Female | Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete | | details | Blood | Detected and Quantified | 0.34 (0.028-0.66) uM | Adult (>18 years old) | Both | ACTH deficiency, isolated | | details | Blood | Detected and Quantified | 0.001 (0.0-0.002) uM | Children (1-13 years old) | Both | Adrenal Hypoplasia | | details | Blood | Detected and Quantified | 0.326 +/- 0.090 uM | Adult (>18 years old) | Both | Schizophrenia | | details | Blood | Detected and Quantified | 10.55 +/- 1.93 uM | Adult (>18 years old) | Both | Schizophrenia | | details | Blood | Detected and Quantified | 0.381 uM | Infant (0-1 year old) | Female | 3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD) | | details | Blood | Detected and Quantified | 0.135 uM | Children (1-13 years old) | Female | Apparent mineralocorticoid excess | | details | Blood | Detected and Quantified | 0.300 +/- 0.200 uM | Newborn (0-30 days old) | Not Specified | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.684-0.991 uM | Adult (>18 years old) | Male | Glucocorticoid resistance | | details | Blood | Detected and Quantified | 0.400 +/- 0.200 uM | Children (1-13 years old) | Not Specified | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.07 uM | Adult (>18 years old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.12 uM | Adolescent (13-18 years old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.290-0.390 uM | Newborn (0-30 days old) | Both | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.280-0.480 uM | Children (1-13 years old) | Both | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.00615 uM | Newborn (0-30 days old) | Male | Glucocorticoid deficiency | | details | Blood | Detected and Quantified | 0.353 uM | Newborn (0-30 days old) | Male | 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency | | details | Blood | Detected and Quantified | 0.360 +/- 0.100 uM | Adult (>18 years old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.230 +/- 0.120 uM | Infant (0-1 year old) | Not Specified | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.300 +/- 0.120 uM | Children (1-13 years old) | Both | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.360 +/- 0.120 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | <0.138 uM | Adult (>18 years old) | Female | Proprotein Convertase 1/3 Deficiency | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Schizophrenia | | details | Blood | Detected and Quantified | <0.0280 uM | Infant (0-1 year old) | Female | Lipoid Adrenal Hyperplasia | | details | Blood | Detected and Quantified | 0.152 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.556 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 2, Antenatal | | details | Blood | Detected and Quantified | 0.434-0.654 uM | Infant (0-1 year old) | Both | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | | details | Blood | Detected and Quantified | 0.558 uM | Children (1-13 years old) | Female | Aromatase deficiency | | details | Blood | Detected and Quantified | 0.27 +/- 0.06 uM | Adult (>18 years old) | Both | Major affective disorder | | details | Blood | Detected and Quantified | 0.0806 uM | Adolescent (13-18 years old) | Female | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | | details | Blood | Detected and Quantified | 0.41 +/- 0.2 uM | Adult (>18 years old) | Both | Tic disorder | | details | Blood | Detected and Quantified | 0.0469 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | | details | Blood | Detected and Quantified | 0.221 uM | Infant (0-1 year old) | Female | Corticosterone methyloxidase I deficiency- CMO I | | details | Blood | Detected and Quantified | <0.1 uM | Adult (>18 years old) | Female | ACTH deficiency, isolated | | details | Blood | Detected and Quantified | 0.22 uM | Children (1-13 years old) | Male | ACTH deficiency, isolated | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0096 (0.0027-0.016) uM | Adult (>18 years old) | Female | Gynecological diseases (benign) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0001+/- 0.00001 uM | Adult (>18 years old) | Female | Functional hypothalamic amenorrhea | | details | Saliva | Detected and Quantified | 8.69 uM | Adult (>18 years old) | Both | Stress period | | details | Urine | Detected and Quantified | 0.021 +/- 0.0097 umol/mmol creatinine | Adult (>18 years old) | Both | Systemic lupus erythematosus (SLE) | | details | Urine | Detected and Quantified | 0.0082 +/- 0.0014 umol/mmol creatinine | Adult (>18 years old) | Both | Systemic lupus erythematosus (SLE) | | details | Urine | Detected and Quantified | 0.0133 umol/mmol creatinine | Adult (>18 years old) | Male | Glucocorticoid resistance | | details | Urine | Detected and Quantified | 0.0114 umol/mmol creatinine | Infant (0-1 year old) | Female | Leptin Deficiency or Dysfunction | | details | Urine | Detected and Quantified | 0.026 +/- 0.011 umol/mmol creatinine | Adult (>18 years old) | Both | Rheumatoid arthritis | | details | Urine | Detected and Quantified | 0.0052 +/- 0.001 umol/mmol creatinine | Adult (>18 years old) | Both | Rheumatoid arthritis | | details | Urine | Detected and Quantified | 0.44 +/- 0.09 umol/mmol creatinine | Adult (>18 years old) | Both | Anorexia nervosa | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Bipolar disorder |
---|
- Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7. [PubMed:11877547 ]
| Tic disorder |
---|
- Hoekstra PJ, Anderson GM, Troost PW, Kallenberg CG, Minderaa RB: Plasma kynurenine and related measures in tic disorder patients. Eur Child Adolesc Psychiatry. 2007 Jun;16 Suppl 1:71-7. doi: 10.1007/s00787-007-1009-1. [PubMed:17665285 ]
| Schizophrenia |
---|
- Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7. [PubMed:11877547 ]
- Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12. [PubMed:21483431 ]
- Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24. [PubMed:22944140 ]
| ACTH deficiency, isolated |
---|
- Harano Y, Kitano A, Akiyama Y, Kotajima L, Honda K, Arioka H: A case of isolated adrenocorticotropic hormone deficiency: a rare but possible cause of hypercalcemia. Int Med Case Rep J. 2015 Mar 27;8:77-9. doi: 10.2147/IMCRJ.S63778. eCollection 2015. [PubMed:25870516 ]
- Aynsley-Green A, Moncrieff MW, Ratter S, Benedict CR, Storrs CN: Isolated ACTH deficiency. Metabolic and endocrine studies in a 7-year-old boy. Arch Dis Child. 1978 Jun;53(6):499-502. [PubMed:210721 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Adrenal hypoplasia |
---|
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Apparent mineralocorticoid excess |
---|
- New MI, Levine LS, Biglieri EG, Pareira J, Ulick S: Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab. 1977 May;44(5):924-33. doi: 10.1210/jcem-44-5-924. [PubMed:870517 ]
| Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
---|
- Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9. [PubMed:7951484 ]
- Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S: Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002 Jun;87(6):2611-22. doi: 10.1210/jcem.87.6.8615. [PubMed:12050224 ]
- Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29. [PubMed:27476613 ]
| Aromatase deficiency |
---|
- Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H: Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab. 1997 Jun;82(6):1739-45. doi: 10.1210/jcem.82.6.3994. [PubMed:9177373 ]
| 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency |
---|
- Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021. [PubMed:9727719 ]
| 3-Hydroxyacyl-CoA dehydrogenase deficiency |
---|
- Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65. [PubMed:11489939 ]
| Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
---|
- Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T: Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res. 2006 Feb;59(2):276-80. doi: 10.1203/01.pdr.0000195825.31504.28. [PubMed:16439592 ]
| Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency |
---|
- Wong SL, Shu SG, Tsai CR: Seventeen alpha-hydroxylase deficiency. J Formos Med Assoc. 2006 Feb;105(2):177-81. doi: 10.1016/S0929-6646(09)60342-9. [PubMed:16477341 ]
- Kim SM, Rhee JH: A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30. [PubMed:26161337 ]
| Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete |
---|
- Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub 2008 Jan 8. [PubMed:18182448 ]
| 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency |
---|
- Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33. [PubMed:23705938 ]
| Bartter Syndrome, Type 2, Antenatal |
---|
- Chan WK, To KF, Tong JH, Law CW: Paradoxical hypertension and salt wasting in Type II Bartter syndrome. Clin Kidney J. 2012 Jun;5(3):217-20. doi: 10.1093/ckj/sfs026. Epub 2012 Mar 29. [PubMed:26069767 ]
| Glucocorticoid resistance |
---|
- Donner KM, Hiltunen TP, Janne OA, Sane T, Kontula K: Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1. Eur J Endocrinol. 2012 Dec 10;168(1):K9-K18. doi: 10.1530/EJE-12-0532. Print 2013 Jan. [PubMed:23076843 ]
| Proprotein Convertase 1/3 Deficiency |
---|
- O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, Gibson S, Taylor K, Carr C: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995 Nov 23;333(21):1386-90. doi: 10.1056/NEJM199511233332104. [PubMed:7477119 ]
| Lipoid Congenital Adrenal Hyperplasia |
---|
- Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T, Strauss JF 3rd: Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest. 1997 Mar 15;99(6):1265-71. doi: 10.1172/JCI119284. [PubMed:9077535 ]
| Corticosterone methyl oxidase I deficiency |
---|
- Ustyol A, Atabek ME, Taylor N, Yeung MC, Chan AO: Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant. J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):356-9. doi: 10.4274/jcrpe.2824. Epub 2016 Apr 29. [PubMed:27125267 ]
| Benign gynecological diseases |
---|
- Murakami K, Nakagawa T, Shozu M, Uchide K, Koike K, Inoue M: Changes with aging of steroidal levels in the cerebrospinal fluid of women. Maturitas. 1999 Sep 24;33(1):71-80. [PubMed:10585175 ]
| Functional hypothalamic amenorrhea |
---|
- Brundu B, Loucks TL, Adler LJ, Cameron JL, Berga SL: Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab. 2006 Apr;91(4):1561-5. Epub 2006 Feb 7. [PubMed:16464944 ]
| Stress |
---|
- Krahwinkel T, Nastali S, Azrak B, Willershausen B: The effect of examination stress conditions on the cortisol content of saliva - a study of students from clinical semesters. Eur J Med Res. 2004 May 28;9(5):256-60. [PubMed:15257879 ]
| Anorexia nervosa |
---|
- Vierhapper H, Kiss A, Nowotny P, Wiesnagrotzki S, Monder C, Waldhausl W: Metabolism of cortisol in anorexia nervosa. Acta Endocrinol (Copenh). 1990 Jun;122(6):753-8. [PubMed:2165347 ]
| Rheumatoid arthritis |
---|
- Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, Scholmerich J, Schedel J: Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2004 Aug;63(8):961-8. [PubMed:15249323 ]
| Leptin Deficiency or Dysfunction |
---|
- Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999 Sep 16;341(12):879-84. doi: 10.1056/NEJM199909163411204. [PubMed:10486419 ]
|
|
---|
Associated OMIM IDs | - 125480 (Bipolar disorder)
- 181500 (Schizophrenia)
- 201400 (ACTH deficiency, isolated)
- 300200 (Adrenal hypoplasia)
- 218030 (Apparent mineralocorticoid excess)
- 201810 (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)
- 613546 (Aromatase deficiency)
- 605911 (3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency)
- 231530 (3-Hydroxyacyl-CoA dehydrogenase deficiency)
- 201750 (Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis)
- 202110 (Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency)
- 613743 (Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete)
- 246450 (3-Hydroxy-3-methylglutaryl-CoA lyase deficiency)
- 241200 (Bartter Syndrome, Type 2, Antenatal)
- 615962 (Glucocorticoid resistance)
- 600955 (Proprotein Convertase 1/3 Deficiency)
- 201710 (Lipoid Congenital Adrenal Hyperplasia)
- 203400 (Corticosterone methyl oxidase I deficiency)
- 606788 (Anorexia nervosa)
- 180300 (Rheumatoid arthritis)
- 614962 (Leptin Deficiency or Dysfunction)
|
---|
External Links |
---|
DrugBank ID | DB00741 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | C00735 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Hydrocortisone |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5754 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17650 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000032 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Hanson, Frederick R.; Mann, Kingsley M.; Nielson, Eldon D.; Anderson, Hugh V.; Brunner, Mari P.; Karnemaat, John N.; Colingsworth, Donald R.; Haines, Wm. J. Microbiological transformations of steroids. VIII. Preparation of 17a-hydroxycorticosterone. Journal of the American Chemical Society 1953, 75(21), p.5369-5370. (https://pubs.acs.org/doi/pdf/10.1021/ja01117a066) |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Schwarz S, Pohl P: Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology. 1992 Feb;55(2):174-82. [PubMed:1620285 ]
- Al-Damluji S, Iveson T, Thomas JM, Pendlebury DJ, Rees LH, Besser GM: Food-induced cortisol secretion is mediated by central alpha-1 adrenoceptor modulation of pituitary ACTH secretion. Clin Endocrinol (Oxf). 1987 May;26(5):629-36. [PubMed:2822298 ]
- Krahwinkel T, Nastali S, Azrak B, Willershausen B: The effect of examination stress conditions on the cortisol content of saliva - a study of students from clinical semesters. Eur J Med Res. 2004 May 28;9(5):256-60. [PubMed:15257879 ]
- Rubin RT, Miller TH, Rhodes ME, Czambel RK: Adrenal cortical responses to low- and high-dose ACTH(1-24) administration in major depressives vs. matched controls. Psychiatry Res. 2006 Jun 30;143(1):43-50. Epub 2006 May 16. [PubMed:16707164 ]
- Morris JG, Nevill ME, Boobis LH, Macdonald IA, Williams C: Muscle metabolism, temperature, and function during prolonged, intermittent, high-intensity running in air temperatures of 33 degrees and 17 degrees C. Int J Sports Med. 2005 Dec;26(10):805-14. [PubMed:16320162 ]
- Deuschle M, Lecei O, Stalla GK, Landgraf R, Hamann B, Lederbogen F, Uhr M, Luppa P, Maras A, Colla M, Heuser I: Steroid synthesis inhibition with ketoconazole and its effect upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans. Neuropsychopharmacology. 2003 Feb;28(2):379-83. Epub 2002 Aug 12. [PubMed:12589391 ]
- Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO: Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005 Sep;116(3):682-8. [PubMed:16140708 ]
- Stark JG, Werner S, Homrighausen S, Tang Y, Krieg M, Derendorf H, Moellmann H, Hochhaus G: Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide. J Pharmacokinet Pharmacodyn. 2006 Aug;33(4):441-59. Epub 2006 Apr 22. [PubMed:16633890 ]
- Makras P, Koukoulis GN, Bourikas G, Papatheodorou G, Bedevis K, Menounos P, Pappas D, Kartalis G: Effect of 4 weeks of basic military training on peripheral blood leucocytes and urinary excretion of catecholamines and cortisol. J Sports Sci. 2005 Aug;23(8):825-34. [PubMed:16195034 ]
- Costa A, Benedetto C, Fabris C, Giraudi GF, Testori O, Bertino E, Marozio L, Varvello G, Arisio R, Ariano M, Emanuel A: Cortisol in human tissues at different stages of life. J Endocrinol Invest. 1996 Jul-Aug;19(7):463-71. [PubMed:8884541 ]
- Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G: Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients. Diabet Med. 2005 Sep;22(9):1146-50. [PubMed:16108840 ]
- Pruessner JC, Baldwin MW, Dedovic K, Renwick R, Mahani NK, Lord C, Meaney M, Lupien S: Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood. Neuroimage. 2005 Dec;28(4):815-26. Epub 2005 Jul 14. [PubMed:16023372 ]
- Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD: Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes. 2002 Apr;51(4):1066-75. [PubMed:11916927 ]
- Takahashi T, Ikeda K, Ishikawa M, Tsukasaki T, Nakama D, Tanida S, Kameda T: Social stress-induced cortisol elevation acutely impairs social memory in humans. Neurosci Lett. 2004 Jun 10;363(2):125-30. [PubMed:15172099 ]
- Chapman TE, Kraan GP, Nagel GT, Wolthers BG, Drayer NM: Measurement of the cortisol production rate in two sisters with 17 alpha-hydroxylase deficiency using [1,2,3,4-13C]cortisol and isotope dilution mass spectrometry. J Steroid Biochem Mol Biol. 1991 Apr;38(4):489-96. [PubMed:2031862 ]
- Heckmann M, Wudy SA, Haack D, Pohlandt F: Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999 Nov;81(3):F171-4. [PubMed:10525017 ]
- Turpeinen U, Markkanen H, Valimaki M, Stenman UH: Determination of urinary free cortisol by HPLC. Clin Chem. 1997 Aug;43(8 Pt 1):1386-91. [PubMed:9267318 ]
- Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG: Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chest. 2005 Jul;128(1):70-7. [PubMed:16002918 ]
- Ritsner M, Gibel A, Maayan R, Ratner Y, Ram E, Biadsy H, Modai I, Weizman A: Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology. 2005 Oct;30(10):1913-22. [PubMed:15870835 ]
- Seidegard J, Dahlstrom K, Kullberg A: Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion. Clin Exp Pharmacol Physiol. 1998 May;25(5):379-81. [PubMed:9612666 ]
- Palacios R, Sugawara I: Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor. Scand J Immunol. 1982 Jan;15(1):25-31. [PubMed:6461917 ]
- de Weerth C, Zijl RH, Buitelaar JK: Development of cortisol circadian rhythm in infancy. Early Hum Dev. 2003 Aug;73(1-2):39-52. [PubMed:12932892 ]
- KNIGHT RP Jr, KORNFELD DS, GLASER GH, BONDY PK: Effects of intravenous hydrocortisone on electrolytes of serum and urine in man. J Clin Endocrinol Metab. 1955 Feb;15(2):176-81. [PubMed:13233328 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|